Research reading
Medicaments: containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale demand and the United States (USA) to Brazil (BRA) lane
Brazil (BRA) reported $3.0M of medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, packaged for retail sale imports in 2019. United States (USA) accounted for 0.1% of the observed market and reported $1.6K in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +15% buyer growth and +3% exporter growth. The page separates reported values from projections and indicators.
